ArticleDiabetes, obesity & metabolism2022

Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.

Rory J McCrimmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.